PD-1 Blockade in Advanced Adrenocortical Carcinoma

PURPOSE: Adrenocortical carcinomas (ACC) are rare and aggressive malignancies with limited treatment options. This study was undertaken to evaluate the immunogenicity of ACC. PATIENTS AND METHODS: Patients with advanced ACC were enrolled in a phase II study to evaluate the clinical activity of pembr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Raj, Nitya, Zheng, Youyun, Kelly, Virginia, Katz, Seth S., Chou, Joanne, Do, Richard K.G., Capanu, Marinela, Zamarin, Dmitriy, Saltz, Leonard B., Ariyan, Charlotte E., Untch, Brian R., O'Reilly, Eileen M., Gopalan, Anuradha, Berger, Michael F., Olino, Kelly, Segal, Neil H., Reidy-Lagunes, Diane L.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7351334/
https://ncbi.nlm.nih.gov/pubmed/31644329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.01586
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados